Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1801–1824 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Leukemia
Interventions: topotecan hydrochloride; Drug
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 21 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2006
U.S. locations: 35
States / cities: Long Beach, California • Los Angeles, California • Orange, California + 27 more

Conditions: Hepatocellular Carcinoma, HCC
Interventions: Stereotactic Body Radiation Therapy (SBRT), Trans-Arterial Chemoembolization (TACE), Doxorubin; Radiation · Procedure · Drug
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Burlington, Massachusetts • Rochester, Minnesota • Omaha, Nebraska + 1 more

Conditions: Moderate to Severe Postoperative Pain
Interventions: Q8003, Morphine sulfate, Oxycodone HCl; Drug
Lead sponsor: QRxPharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 522 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 5
States / cities: Anaheim, California • Owings Mills, Maryland • Pasadena, Maryland + 2 more

Conditions: Asthma
Interventions: Enhanced Pharmacy Care, Control; Behavioral
Lead sponsor: Stephen J. Teach, MD, MPH; Other
Eligibility: 12 Months to 12 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Multiple Sclerosis, Gait Disorders, Neurologic, Motility Disorder, Cognitive Impairment
Interventions: Robotic Exoskeleton Rehabilitation, Conventional Gait Therapy; Device · Other
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Type 1 Diabetes
Interventions: Remote Patient Monitoring; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 1 Year to 20 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Myopia, Astigmatism
Interventions: Wavefront-guided LASIK, Wavefront-optimized LASIK; Procedure
Lead sponsor: Edward E. Manche; Other
Eligibility: 21 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Ewing Sarcoma, Rhabdomyosarcoma
Interventions: Olaparib, Temozolomide, Irinotecan; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 16 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2025
U.S. locations: 5
States / cities: Boston, Massachusetts • Memphis, Tennessee

Conditions: Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome
Interventions: Navitoclax, Venetoclax, Decitabine, Bone Marrow Biopsy, Biospecimen Collection, Laboratory Biomarker Analysis, Quality-of-Life Assessment; Biological · Drug · Procedure + 1 more
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pain, Anxiety
Interventions: Buzzy, Topical Lidocaine 4% Cream; Device · Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Years to 18 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Emotions
Interventions: Mindful Breathing, Habituation, Control; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Spinal Cord Injuries, Pain, Neuropathic
Interventions: Alpha-Stim M; Device
Lead sponsor: SCI Research Advancement; Other
Eligibility: Not listed
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Buellton, California

Conditions: Lung Cancer
Interventions: RAD001; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Breast Cancer, Metastatic Cancer
Interventions: capecitabine, cyclophosphamide, doxorubicin hydrochloride, gemcitabine hydrochloride, lapatinib ditosylate, paclitaxel, vinorelbine ditartrate, Trastuzumab; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: New York, New York • Cleveland, Ohio

Conditions: Depression
Interventions: Behavioral Activation; Behavioral
Lead sponsor: National Center for Telehealth and Technology; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Portland, Oregon • Tacoma, Washington

Conditions: Breast Cancer
Interventions: Green tea extract supplement, Placebo; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 1,075 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 5
States / cities: Edina, Minnesota • Maple Grove, Minnesota • Minneapolis, Minnesota + 2 more

Conditions: Lysosomal Acid Lipase Deficiency, Wolman Disease
Interventions: Sebelipase alfa (SBC-102); Drug
Lead sponsor: Alexion Pharmaceuticals, Inc.; Industry
Eligibility: Up to 24 Months
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Irvine, California

Conditions: Chronic Female Pelvic Pain Syndrome (Disorder)
Interventions: Mindfulness counseling; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Renal Insufficiency, Healthy
Interventions: Canagliflozin (JNJ-28431754); Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 3
States / cities: Orlando, Florida • Minneapolis, Minnesota • Knoxville, Tennessee

Conditions: Posttraumatic Stress Symptoms, Burnout, Burnout, Healthcare Workers, First Responders, PTSD, Healthcare Workforce Well-Being, Post-traumatic Stress Symptoms
Interventions: Floatation-REST, Documentary; Behavioral
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 64 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Familial Hypercholesterolemia
Interventions: Cascade Screening; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Smoking Cessation
Interventions: Smart-T + NRT, QuitGuide + NRT; Combination Product
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 454 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Back Pain, Intervertebral Disc Degeneration
Interventions: Physical Therapy; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 30 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cognitive Impairment, Progressive, Cerebral Small Vessel Diseases
Interventions: High-Speed Circuit Resistance Training, Lecture on Diet, Exercise and Cognition; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 65 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Coral Gables, Florida

Search by objective public record fields.

Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant

Comparison of the Efficacy and Safety of Q8003 Versus Its Individual Components in Bunionectomy Patients

Involving Community Pharmacies in Improving Asthma Outcomes in an Urban Pediatric Population

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

Wavefront-guided Versus Wavefront-optimized LASIK for Nearsightedness

Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief

Emotion Regulation and Emotion Perception

Using NI-ES to Treat Spinal Cord Injury (SCI)

Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Chemotherapeutic Agents in Brain/Breast

A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression

Green Tea and Reduction of Breast Cancer Risk

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency

The Impact of Integrative Medicine on Patient-Reported Outcomes in Management of Chronic Pelvic Pain

A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function

FLOAT for Healthcare PTSS

Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia

Smartphone Based Smoking Cessation Intervention

The Role of Disc Nutrition in the Etiology and Clinical Treatment of Disc Degeneration

Circuit Training and Retina